|
Volumn 38, Issue 3, 2002, Pages 401-408
|
A Danish population-based analysis of 105 mantle cell lymphoma patients: Incidences, clinical features, response, survival and prognostic factors
|
Author keywords
Clinical features; Incidence; Mantle cell lymphoma; Population based; Prognosis; Survival
|
Indexed keywords
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
DAUNORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
METHOTREXATE;
MITOGUAZONE;
MITOXANTRONE;
PREDNISONE;
VINCRISTINE SULFATE;
AGE;
AGED;
ANEMIA;
ARTICLE;
CANCER INCIDENCE;
CANCER STAGING;
CANCER SURVIVAL;
CANCER THERAPY;
CLINICAL FEATURE;
CONTROLLED STUDY;
DECISION MAKING;
DENMARK;
EVALUATION;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MANTLE CELL LYMPHOMA;
MULTIVARIATE ANALYSIS;
POPULATION RESEARCH;
PRIORITY JOURNAL;
PROGNOSIS;
RADIOTHERAPY;
SPLENOMEGALY;
TREATMENT OUTCOME;
AGE DISTRIBUTION;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DENMARK;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
INCIDENCE;
LYMPHOMA, MANTLE-CELL;
MALE;
MULTIVARIATE ANALYSIS;
NEOPLASM STAGING;
POPULATION SURVEILLANCE;
PROGNOSIS;
|
EID: 0036159487
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(01)00366-5 Document Type: Article |
Times cited : (76)
|
References (24)
|